TIVf

BIOLOGICAL3 trials

Sponsors

Novartis Vaccines

Conditions

Human InfluenzaProphylaxis: InfluenzaSeasonal Influenza

Phase 3

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

CompletedNCT01209780

Novartis VaccinesSeasonal Influenza

Start: 2010-09-30End: 2011-09-30Updated: 2014-03-11

Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above

CompletedNCT01885117

Novartis VaccinesHuman Influenza

Start: 2013-08-31End: 2013-09-30Updated: 2014-03-12

Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects

CompletedNCT02256488

Novartis VaccinesProphylaxis: Influenza

Start: 2014-09-30End: 2014-12-31Updated: 2019-06-11